- Home
- FOXX vs ESLA Comparison
FOXX vs ESLA Comparison
Compare FOXX & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXX
- ESLA
- Stock Information
- Founded
- FOXX 2017
- ESLA 2021
- Country
- FOXX United States
- ESLA United States
- Employees
- FOXX N/A
- ESLA N/A
- Industry
- FOXX
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FOXX
- ESLA Health Care
- Exchange
- FOXX Nasdaq
- ESLA Nasdaq
- Market Cap
- FOXX 32.2M
- ESLA 35.9M
- IPO Year
- FOXX N/A
- ESLA N/A
- Fundamental
- Price
- FOXX $5.23
- ESLA $1.12
- Analyst Decision
- FOXX
- ESLA Strong Buy
- Analyst Count
- FOXX 0
- ESLA 1
- Target Price
- FOXX N/A
- ESLA $16.00
- AVG Volume (30 Days)
- FOXX 28.4K
- ESLA 35.9K
- Earning Date
- FOXX 11-18-2025
- ESLA 08-12-2025
- Dividend Yield
- FOXX N/A
- ESLA N/A
- EPS Growth
- FOXX N/A
- ESLA N/A
- EPS
- FOXX N/A
- ESLA N/A
- Revenue
- FOXX $53,866,257.00
- ESLA N/A
- Revenue This Year
- FOXX N/A
- ESLA N/A
- Revenue Next Year
- FOXX N/A
- ESLA N/A
- P/E Ratio
- FOXX N/A
- ESLA N/A
- Revenue Growth
- FOXX 3899.98
- ESLA N/A
- 52 Week Low
- FOXX $2.45
- ESLA $0.63
- 52 Week High
- FOXX $12.80
- ESLA $1.78
- Technical
- Relative Strength Index (RSI)
- FOXX 43.70
- ESLA 63.62
- Support Level
- FOXX $4.51
- ESLA $1.04
- Resistance Level
- FOXX $5.86
- ESLA $1.23
- Average True Range (ATR)
- FOXX 0.61
- ESLA 0.07
- MACD
- FOXX -0.05
- ESLA 0.01
- Stochastic Oscillator
- FOXX 35.52
- ESLA 56.00
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.